Dismiss Notice
Food and Drug Administration (FDA) Disclosure:

The statements in this forum have not been evaluated by the Food and Drug Administration and are generated by non-professional writers. Any products described are not intended to diagnose, treat, cure, or prevent any disease.

Website Disclosure:

This forum contains general information about diet, health and nutrition. The information is not advice and is not a substitute for advice from a healthcare professional.

Stacking the research deck

Discussion in 'Medical Cannabis: Treatments & Patient Experiences' started by peanutbutter, Jan 29, 2010.

  1. #1 peanutbutter, Jan 29, 2010
    Just in from NORML:

    Rockville, MD: A spokesperson for the U.S. National Institute on Drug Abuse (NIDA) told the New York Times last week that the agency does "not fund research focused on the potential medical benefits of marijuana."
    Under federal law, the agency must approve all clinical and preclinical research involving marijuana. NIDA strictly controls which investigators are allowed access to the federal government's lone research supply of pot – which is produced and stored at the University of Mississippi.
    NIDA spokeswoman Shirley Simson told the Times: "As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana."
    NIDA presently oversees an estimated 85 percent of the world's research on controlled substances.
    Commenting on NIDA's admission NORML Deputy Director Paul Armentano said, "NIDA has finally admitted to the world the 'Catch-22' that has been plaguing medical marijuana advocates and patients. Lawmakers demand clinical research regarding the safety and efficacy of medical cannabis, but the agency in charge of such research denies these studies from ever taking place. It's tragic that these public officials have let political ideology, not science, determine American's health decisions."
    In 2007, U.S. Drug Enforcement Administration (DEA) Administrative Law Judge Mary Ellen Bittner ruled that NIDA's monopolization of marijuana research is not "in the public interest," and ordered the federal government to allow private manufacturers to produce the drug for research purposes. In January of last year, DEA Deputy Administrator Michele Leonhart set aside Judge Bittner's ruling.
    This week President Barack Obama announced his selection of Leonhart to be the DEA's Director.
    For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.
     
  2. #2 stickey_fingerz, Jan 29, 2010
    WOWWOWOWOWOWOWOWOWOWOWOWOWOWOWOWOW:eek::eek::eek::eek::eek::eek::eek::eek::eek:... THIS IS COMPLETE AND UTTER BULLSHIT, I MEAN REALLY ITS NOT SURPRISING BUT STILL HOW THE FUCK CAN YOU SAY WE HAVEN'T DONE ENOUGH RESEARCH TO MAKE A CHANGE TO OUR DRUG LAWS... when really its not that theres not enough research but that the leading research funder simply refuses to research marijuana for medical benefits PERIOD... im fucking furious i cant even put my thoughts together wow...
     
  3. #3 robxmosh, Jan 29, 2010
    Fuckin comical.
     
  4. #4 Trogdole, Jan 29, 2010
    Once again guys, there's a way to voice your opinion on this.

    Google Moderator

    You need a google account, but in health care, on the first page is a question directly asking Obama if he will tell the DEA and NIDA to stop blocking these studies.
     
  5. #5 peanutbutter, Jan 29, 2010
    I think it goes like this:

    The fed funds the U of Miss. farm.

    The only source of material that you are allowed to use comes from there.
    IF the DEA will issue you a permit.

    It's not that funding isn't available .. it's that federally funded marijuana isn't available.
     

Share This Page